-
Weight loss drugs tied to fewer anxiety, depression cases: Study
Patients who take Ozempic, Mounjaro and Wegovy are less likely to be diagnosed with anxiety or depression compared to those who don't receive the popular diabetes and weight loss drugs, according to a new study. -
Mercy hospital to move pharmacy, add oncology services
Cincinnati-based Mercy Health is moving its Urbana (Ohio) Hospital's pharmacy from a small hallway space near the emergency department to its own space in 2024. -
Prevent drug shortages, save hospitals $550M: AHA
Drug shortages inflict more than $550 million in additional costs every year on hospitals and health systems, the American Hospital Association said in a letter to Congress. -
Automation delivers much-needed relief to a strained healthcare workforce
Hospitals and health systems are currently experiencing what many consider to be a labor crisis – particularly among caregivers. -
Newly acquired Novo Nordisk plant struggles to meet quality standards, FDA finds
Last fall, FDA inspectors found multiple safety and quality issues at one of the manufacturing sites Novo Nordisk has agreed to purchase, according to a Feb. 6 Bloomberg report. -
Zepbound, Mounjaro show potential for fatty liver disease
Eli Lilly's phase 2 study of Mounjaro and Zepbound found promising results for the medications to treat fatty liver disease, the drugmaker said Feb. 6. -
FDA to consider RSV vaccine for adults in their 50s
Respiratory syncytial virus vaccinations could soon extend to adults aged 50-59. -
5 Ozempic updates
In 2024, the cost of Ozempic increased 3.5% as health systems, payers and patients scramble to manage the drug's soaring popularity. -
Zepbound may significantly lower blood pressure in overweight adults, new study finds
Eli Lilly's ingredient for Type 2 diabetes medication Mounjaro and its new weight loss drug, Zepbound, significantly lowered patients' blood pressure by up to 10.6 mmHg, according to a new study published Feb. 5. -
Walgreens, pharmacy schools to boost talent pipeline
Walgreens has formed a new advisory council with pharmacy school leaders to address staffing challenges and fortify the pipeline of future pharmacists. -
Novo Nordisk to buy 3 fill-finish sites in $11B deal
As Novo Nordisk increases the output of its popular weight loss drug Wegovy, the Denmark-based drugmaker agreed to buy three fill-finish manufacturing sites for $11 billion. -
Yale New Haven to open new pharmacy
Yale New Haven (Conn.) Health is opening its fourth pharmacy Feb. 6, which will offer home deliveries, according to a news release shared with Becker's. -
In 4 months, NYC Health + Hospitals mails 230 abortion kits
In October, NYC Health + Hospitals became the first public health system in the U.S. to launch telehealth abortion access, which includes medication abortion for eligible patients. -
For 1st time in 20 years, US broadens access to methadone
Flexibilities for the opioid use disorder treatment methadone made during the COVID-19 pandemic have now been made permanent, HHS said Feb. 1, marking the first substantial changes to its regulations in 20 years. -
2 more cancer drug injectables fall into shortage
Multiple solutions of etoposide and topotecan are on back order. -
Top 20 pharmacy schools for first-time NAPLEX pass rates
First-time pass rates for the North American Pharmacist Licensure Examination have slightly dipped in the past two years, according to data from the National Association of Boards of Pharmacy. -
Government, pharma companies initiate price talks for 10 of the most expensive drugs
Feb.1 marks the first day that federal officials will negotiate the price for 10 of the most expensive drugs as part of the Biden administration's Inflation Reduction Act, The Hill reported. -
What an 'obesity bill of rights' means for medical care amid the rise of weight loss drugs
Among the rise in popularity of weight-loss drugs, an "obesity bill of rights" has been published and endorsed by nearly 40 national obesity, and chronic disease organizations, with the aim to have providers incorporate the standards into medical practice. -
ASHP elects 5 leaders to digital, telehealth committee
On Feb. 1, the American Society of Health-System Pharmacists appointed five leaders to its new digital and telehealth practitioners committee. -
Top 15 pharmacy schools by NAPLEX pass rates
The average all-time pass rate of the North American Pharmacist Licensure Examination was 75.7% in 2023 — a slight increase from the year prior, according to data from the National Association of Boards of Pharmacy.
Page 10 of 50